HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized ...
4d
HeartBeam (NASDAQ: BEAT) Outlines Regulatory Strategy After NSE Decision on ECG Synthesis Software
HeartBeam (NASDAQ: BEAT), a medical technology company developing personalized cardiac-care insights, detailed its ...
SANTA CLARA, Calif., April 29, 2025--(BUSINESS WIRE)--HeartBeam, Inc., (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, ...
PH is a progressive, life-threatening pulmonary vascular disease estimated to affect up to 1% of the global population. 1 It is often difficult to diagnose 2 due to non-specific early symptoms, such ...
These are the most basic ECG devices. They are generally used for monitoring the heart, checking for arrhythmias, etc. Nowadays, the portable and wearable health monitoring devices also include ...
HeartBeam has received FDA clearance for its synthesized 12-lead ECG software, making it the first cable-free device of its kind for at-home arrhythmia assessment. The clearance followed a successful ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, ...
LOS ANGELES, CA - December 10, 2025 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, received FDA 510(k) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results